XPNPEP2 and posterior cortical atrophy: To validate the potential usefulness of serum XPNPEP2 as a noninvasive biomarker for predicting the risk of lymph node involvement in Pca patients, an Receiver operating characteristic (ROC) curve analysis was performed using serum XPNPEP2 levels alone or in combination with PSA.